{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T11:06:20Z","timestamp":1771067180243,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shaanxi Provincial Key Research and Development Program","award":["No.2022SF-367"],"award-info":[{"award-number":["No.2022SF-367"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-03158-x","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T09:02:29Z","timestamp":1719219749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparing ranibizumab, dexamethasone implant, and combined therapy for macular edema secondary to branch retinal vein occlusion: a clinical trial"],"prefix":"10.1007","volume":"44","author":[{"given":"Li","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuguang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7682-9282","authenticated-orcid":false,"given":"Xiaodong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,24]]},"reference":[{"key":"3158_CR1","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.09.010427","author":"P Song","year":"2019","unstructured":"Song P, Xu Y, Zha M, Zhang Y, Rudan I (2019) Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Global Health. https:\/\/doi.org\/10.7189\/jogh.09.010427","journal-title":"J Global Health"},{"issue":"12","key":"3158_CR2","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.oret.2022.06.016","volume":"6","author":"TA Ciulla","year":"2022","unstructured":"Ciulla TA, Kapik B, Hu A, Harris A, Ip MS, Blodi B (2022) Anatomic biomarkers of macular edema associated with retinal vein occlusion. Ophthalmol Retin 6(12):1206\u20131220","journal-title":"Ophthalmol Retin"},{"key":"3158_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1155\/2017\/4936924","volume":"2017","author":"J Li","year":"2017","unstructured":"Li J, Paulus YM, Shuai Y, Fang W, Liu Q, Yuan S (2017) New developments in the classification, pathogenesis, risk factors, natural history, and treatment of branch retinal vein occlusion. J Ophthalmol 2017:15","journal-title":"J Ophthalmol"},{"issue":"1","key":"3158_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ophtha.2013.08.038","volume":"121","author":"PA Campochiaro","year":"2014","unstructured":"Campochiaro PA, Sophie R, Pearlman J, Brown DM, Boyer DS, Heier JS et al (2014) Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. Ophthalmology 121(1):209\u2013219","journal-title":"Ophthalmology"},{"issue":"10","key":"3158_CR5","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.ophtha.2011.02.038","volume":"118","author":"PA Campochiaro","year":"2011","unstructured":"Campochiaro PA, Brown DM, Awh CC, Lee SY, Gray S, Saroj N et al (2011) Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology 118(10):2041\u20132049","journal-title":"Ophthalmology"},{"issue":"12","key":"3158_CR6","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1016\/j.ophtha.2011.05.014","volume":"118","author":"JA Haller","year":"2011","unstructured":"Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J et al (2011) Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results. Ophthalmology 118(12):2453\u20132460","journal-title":"Ophthalmology"},{"key":"3158_CR7","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00417-016-3350-x","volume":"254","author":"JG Garweg","year":"2016","unstructured":"Garweg JG, Zandi S (2016) Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex\u00ae) in its treatment. Graefes Arch Clin Exp Ophthalmol 254:1257\u20131265","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3158_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12886-021-01857-y","volume":"21","author":"S Bhandari","year":"2021","unstructured":"Bhandari S, Poudel M, Paudyal I, Joshi PL, Shrestha C, Paudyal G, Pradhan E (2021) Treatment outcomes of retinal vein occlusion in clinical practice in Nepal. BMC Ophthalmol 21:1\u20139","journal-title":"BMC Ophthalmol"},{"issue":"7","key":"3158_CR9","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1167\/iovs.17-23437","volume":"59","author":"A Winegarner","year":"2018","unstructured":"Winegarner A, Wakabayashi T, Fukushima Y, Sato T, Hara-Ueno C, Busch C et al (2018) Changes in retinal microvasculature and visual acuity after antivascular endothelial growth factor therapy in retinal vein occlusion. Invest Ophthalmol Vis Sci 59(7):2708\u20132716","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3158_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10384-022-00969-2","volume":"67","author":"Y Hashimoto","year":"2023","unstructured":"Hashimoto Y, Okada A, Matsui H, Yasunaga H, Aihara M, Obata R (2023) Recent trends in anti-vascular endothelial growth factor intravitreal injections: a large claims database study in Japan. Jpn J Ophthalmol 67(1):109\u2013118","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"3158_CR11","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1177\/1120672120947595","volume":"31","author":"R Pranata","year":"2021","unstructured":"Pranata R, Vania A, Vania R, Victor AA (2021) Intravitreal ranibizumab versus dexamethasone implant in macular edema due to branch retinal vein occlusion: systematic review and meta-analysis. Eur J Ophthalmol 31(4):1907\u20131914","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"3158_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.oret.2019.08.001","volume":"4","author":"Wei W, Weisberger A, Zhu L, Cheng Y, Liu C, Group BS","year":"2020","unstructured":"Wei W, Weisberger A, Zhu L, Cheng Y, Liu C, Group BS (2020) Efficacy and safety of ranibizumab in Asian patients with branch retinal vein occlusion: results from the randomized BLOSSOM study. Ophthalmol Retin 4(1):57\u201366","journal-title":"Ophthalmol Retin"},{"issue":"8","key":"3158_CR13","doi-asserted-by":"publisher","first-page":"e933","DOI":"10.1111\/aos.13770","volume":"96","author":"N Feltgen","year":"2018","unstructured":"Feltgen N, Hattenbach LO, Bertelmann T, Callizo J, Rehak M, Wolf A et al (2018) Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study. Acta Ophthalmol 96(8):e933\u2013e941","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"3158_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1089\/jop.2017.0148","volume":"34","author":"G Garay-Aramburu","year":"2018","unstructured":"Garay-Aramburu G, G\u00f3mez-Moreno \u00c1 (2018) A 5-Year follow-up study of the treatment of macular edema due to retinal vein occlusion using dexamethasone intravitreal implants. J Ocul Pharmacol Ther 34(6):436\u2013441","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"3158_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000381187","volume":"53","author":"F Bandello","year":"2015","unstructured":"Bandello F, Parravano M, Cavallero E, Cascavilla ML, Triolo G, Querques L et al (2015) Prospective evaluation of morphological and functional changes after repeated intravitreal dexamethasone implant (Ozurdex\u00ae) for retinal vein occlusion. Ophthalmic Res 53(4):207\u2013216","journal-title":"Ophthalmic Res"},{"issue":"3","key":"3158_CR16","first-page":"131","volume":"4","author":"AH Bayat","year":"2019","unstructured":"Bayat AH, B\u00f6l\u00fckbasi S, Erden B, Cakir A, Ozturan SG, Tayfur M, Elcioglu MN (2019) A real-life study: intravitreal aflibercept, ranibizumab and dexamethasone for macular edema secondary to branch retinal vein occlusion. Beyoglu Eye J 4(3):131\u2013135","journal-title":"Beyoglu Eye J"},{"issue":"6","key":"3158_CR17","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41433-019-0616-7","volume":"34","author":"A Sharma","year":"2020","unstructured":"Sharma A, Kuppermann BD, Bandello F, Lanzetta P, Zur D, Park SW et al (2020) Intraocular pressure (IOP) after intravitreal dexamethasone implant (Ozurdex) amongst different geographic populations\u2014GEODEX-IOP study. Eye 34(6):1063\u20131068","journal-title":"Eye"},{"key":"3158_CR18","doi-asserted-by":"publisher","first-page":"861757","DOI":"10.3389\/fendo.2022.861757","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Cao X, Zhao M, Bao Y (2022) The changes of irisin and inflammatory cytokines in the age-related macular degeneration and retinal vein occlusion. Front Endocrinol 13:861757","journal-title":"Front Endocrinol"},{"issue":"1","key":"3158_CR19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/1120672119885054","volume":"31","author":"H Noma","year":"2021","unstructured":"Noma H, Yasuda K, Shimura M (2021) Change of cytokines after intravitreal ranibizumab in patients with recurrent branch retinal vein occlusion and macular edema. Eur J Ophthalmol 31(1):204\u2013210","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"3158_CR20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/eye.2017.230","volume":"32","author":"P Lip","year":"2018","unstructured":"Lip P, Cikatricis P, Sarmad A, Damato E, Chavan R, Mitra A et al (2018) Efficacy and timing of adjunctive therapy in the anti-VEGF treatment regimen for macular oedema in retinal vein occlusion: 12-month real-world result. Eye 32(3):537\u2013545","journal-title":"Eye"},{"key":"3158_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/OPTH.S119373","volume":"11","author":"MA Singer","year":"2016","unstructured":"Singer MA, Jansen ME, Tyler L, Woods P, Ansari F, Jain U et al (2016) Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series. Clin Ophthalmol 11:31\u201338","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"3158_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4103\/meajo.MEAJO_297_19","volume":"28","author":"W Harb","year":"2021","unstructured":"Harb W, Chidiac G, Harb G (2021) Outcomes of combination therapy using aflibercept and dexamethasone intravitreal implant versus dexamethasone monotherapy for macular edema secondary to retinal vein occlusion. Middle East Afr J Ophthalmol 28(1):18","journal-title":"Middle East Afr J Ophthalmol"},{"key":"3158_CR23","doi-asserted-by":"publisher","first-page":"930508","DOI":"10.3389\/fmed.2022.930508","volume":"9","author":"X Liang","year":"2022","unstructured":"Liang X, Shen B, Ou Z, An H, Li L (2022) Comparison of intravitreal ranibizumab monotherapy vs. ranibizumab combined with dexamethasone implant for macular edema secondary to retinal vein occlusion. Front Med 9:930508","journal-title":"Front Med"},{"issue":"2","key":"3158_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.4103\/ijo.IJO_684_21","volume":"70","author":"V Sweta","year":"2022","unstructured":"Sweta V, Dev BS, Sandhya R (2022) Secondary glaucoma after intravitreal dexamethasone implant (Ozurdex) injection in patients with retinal disorder: a retrospective study. Indian J Ophthalmol 70(2):585","journal-title":"Indian J Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03158-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03158-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03158-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:44:54Z","timestamp":1741880694000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03158-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,24]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3158"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03158-x","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,24]]},"assertion":[{"value":"17 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All of the authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"262"}}